Aflac Incorporated

Aflac's strong profitability metrics — including a 25.32% net income margin and 16.47% ROE — alongside its reputation as a dividend aristocrat justify a premium valuation. The stock's recent upward momentum and bullish technical signals from moving averages support the case that current price levels are sustainable.

With a consensus price target of $114.50–$117.50 against a current trading price near $124–$125, the majority of covering analysts rate AFL a Hold, with 4 Sells among 17 analysts. The updated average target implies approximately 5–8% downside, suggesting the stock is overvalued at current levels.

After a revenue decline to $17.36B in 2025, Aflac's revenue is projected to recover to $18.3B in 2026. The company maintains solid cash flow generation and strong Japan market performance, suggesting the revenue dip is temporary and that fundamentals remain intact for a rebound.

Aflac has missed earnings expectations in two of the last three quarters, and revenue has already declined in 2025. This pattern of earnings volatility raises concerns about execution and the reliability of future growth projections, undermining confidence in a near-term recovery.

Aflac holds buy signals from both short- and long-term moving averages, and a pivot bottom buy signal issued in mid-July 2025 has already yielded a 2.73% gain. Nasdaq Dorsey Wright highlights AFL as a top-half sector matrix performer with positive long-term market and peer relative strength.

Despite short-term buy signals, a sell signal persists from the 3-month MACD, and a volume-price divergence has emerged as a warning indicator. The stock is caught in a falling short-term trend, with a 90% probability model projecting a price decline of nearly 4% over the next three months.